Cargando…
miR-22 suppresses tumorigenesis and improves radiosensitivity of breast cancer cells by targeting Sirt1
BACKGROUND: miR-22 has been shown to be frequently downregulated and act as a tumor suppressor in multiple cancers including breast cancers. However, the role of miR-22 in regulating the radioresistance of breast cancer cells, as well as its underlying mechanism is still not well understood. METHODS...
Autores principales: | Zhang, Xia, Li, Yuehua, Wang, Dan, Wei, Xiaoer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590131/ https://www.ncbi.nlm.nih.gov/pubmed/28882183 http://dx.doi.org/10.1186/s40659-017-0133-8 |
Ejemplares similares
-
miR-22 in tumorigenesis
por: Song, Su Jung, et al.
Publicado: (2014) -
MiR-34a Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting SIRT1
por: Liu, Yang, et al.
Publicado: (2020) -
miR‐22
enhances the radiosensitivity of small‐cell lung cancer by targeting the
WRNIP1
por: Jiang, Wenhua, et al.
Publicado: (2019) -
MiR-19b suppresses PTPRG to promote breast tumorigenesis
por: Liu, Minghui, et al.
Publicado: (2016) -
miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ
por: Wang, Xuehui, et al.
Publicado: (2021)